1.Application and practice of indocyanine green-guided laparoscopic radical gastrec-tomy for gastric cancer
Huang CHANGMING ; Liang HAN ; Zheng CHAOHUI ; Chen QIYUE ; Zhong QING ; Qiu TAOYUAN
Chinese Journal of Clinical Oncology 2024;51(13):663-669
Indocyanine green(ICG)near-infrared imaging technology has significant research value in laparoscopic radical gastrectomy and has garnered widespread attention and research both domestically and internationally.However,the application of ICG near-infrared ima-ging technology in laparoscopic radical gastrectomy is still in the exploratory stage in current clinical practice,with no unified standards es-tablished as yet.This review introduces the mechanism of ICG fluorescence imaging and discusses the indications and contraindications of ICG use in laparoscopic radical gastrectomy.The application methods and procedures of ICG molecular fluorescence imaging technology in laparoscopic radical gastrectomy and its clinical applications are elaborated upon.Finally,the practical applications of ICG-guided laparo-scopic radical gastrectomy is summarized and generalized to help facilitate its promotion and further standardization.
2.Compliance of sepsis hour-1 bundle strategy for patients with septic shock in emergency department
Liang XU ; Zhiwei GAO ; Weiqin WU ; Yadong YU ; Weijun GUO ; Qi LI ; Changming ZHAO ; Yujun CHEN ; Siwei WANG ; Hongmei ZHAO ; Hong SUN ; Jinsong ZHANG
Chinese Journal of General Practitioners 2022;21(1):42-47
Objective:To investigate the implementation status of sepsis hour-1 bundle strategy for patients with septic shock in emergency department.Methods:A total of 116 septic shock patients admitted to the emergency department from January 2020 to December 2020 were included in this prospective study, and the implementation of sepsis bundles and the clinical outcomes of patients were recorded.Results:Among 116 patients, 20 cases (17.2%) had lactic acid monitored within 1 h, 20 cases (17.2%) had blood culture before antibiotics, 82 cases (70.1%) received broad-spectrum antibiotics, 16 cases (13.8%) received fluid resuscitation ≥30 ml/kg, and 57 cases (49.1%) received vasoactive drugs during resuscitation. Finally, the sepsis hour-1 bundle strategy was fully implemented only in 13 cases (11.2%). Compared with the group with incomplete implementation of sepsis hour-1 bundle strategy, the volume of fluid recovery in the group with full implementation was significantly increased [33.7 (30.0,37.5) vs. 8.9(7.3,10.8) ml/kg, Z=-4.78, P<0.001], mean artery blood pressure significantly increased [70.0 (70.0,76.7) vs. 67.7 (61.7,76.7)mmHg(1 mmHg=0.133 kPa) , Z=-2.00, P<0.001], and lactic acid significantly decreased [3.0 (2.0,3.2) vs. 4.4 (3.7,7.2) mmol/L, Z=-2.76, P=0.006]. However, there were no significant differences in ICU mortality, in-hospital mortality and 28-day mortality between the two groups ( P>0.05). Conclusions:Septic shock patients in emergency department have poor compliance with the implementation of sepsis hour-1 bundle strategy, and relevant management training should be strengthened.
3.Case-control study of the risk of esophageal cancer in Xinjiang
Zhipeng WANG ; Haiping ZHANG ; Liang ZONG ; Qingchao SUN ; Changming ZHANG
Chinese Journal of Clinical Oncology 2017;44(2):92-95
Objective:To explore the characteristics of prevailing factors and their influence on esophageal cancer in Xinjiang. Meth-ods:Patients diagnosed with esophageal cancer from January 2010 to January 2016 were selected from the Xinjiang Medical Universi-ty First Affiliated Hospital and categorized as the patient group. Patients without cancer admitted to the same period were classified as the control group. Case control study and correlation analysis between esophageal cancer and type 2 diabetes were performed. Re-sults:Type 2 diabetes (≥2 years), as a risk factor, is associated with esophageal cancer. The use of insulin (≥2 years) can increase the risk of esophageal cancer. Smoking, drinking, hyperlipidemia, body mass index≥24, and esophageal diverticulum esophageal cancer are also risk factors. Conclusion:The risk factors for esophageal cancer are prevalent among patients with type 2 diabetes patients. In-sulin use is also correlated with the occurrence of esophageal cancer. Further studies must be performed to develop secondary preven-tion for diabetic patients susceptible to esophageal cancer in high-risk subgroups.
4.Learning and Memory Deficit and Demyelination of Corpus Callosum in APP/PS1 Transgenic Mice
Xiufeng ZHANG ; Hao JIN ; Bingbing LIN ; Long LI ; Changming SONG ; Zuanfang LI ; Shengxiang LIANG ; Jingjie MAO ; Weilin LIU ; Jing TAO ; Lidian CHEN
Chinese Journal of Rehabilitation Theory and Practice 2017;23(9):1027-1031
Objective To investigate the relationship between learning and memory deficit and demyelination of the corpus callosum in twelve-month old APP/PS1 transgenic mice. Methods Twelve twelve-month old APP/PS1 transgenic mice were as AD group, and age-matched wild type (WT) littermates were as WT group. Learning and memory ability was tested with Morris water maze, and the mor-phology of nerve fiber of corpus callosum was detected with Luxol Fast Blue staining. Immunohistochemistry was used to detect myelin ba-sic protein (MBP) in the corpus callosum. Thioflavine S staining was used to detect amyloid plaque in the corpus callosum. Results Com-pared with WT group, the latency increased (Z>2.873, P<0.01) and the times crossing the location of the platform decreased (t=-7.339, P<0.001) in AD group. The nerve fibers were sparse and disorganized, with a lot of vacuoles in the corpus callosum of AD group. The positive expression of MBP in the corpus callosum was significantly decreased (t=-4.481, P<0.001) in AD group compared with WT group. There were amyloid plaques in the corpus callosum of AD group. Conclusion Twelve-month old APP/PS1 transgenic mice exhibit learning and memory deficit, which may be attributed to the deposition of the amyloid plaque mediated demyelinated injury of the corpus callosum.
5.Use of second time window principle for thrombolysis in chronic lower limb ischemia
Fuxian ZHANG ; Xiaoyun LUO ; Changming ZHANG ; Gangzhu LIANG ; Yaping FENG ; Huan ZHANG ; Luyuan NIU
Chinese Journal of General Surgery 2017;32(11):930-932
Objective To evaluate the safety and efficacy of preparatory catheter-directed thrombolysis together with assisted endovascular angioplasty in treating chronic occlusive arterial disorders of lower extrenities under the second time window principle for thrombolysis.Methods From Jan 2001 to Dec 2014,preparatory catheter-directed thrombolysis together with assisted endovascular angioplasty was performed in 206 patients with chronic occlusive arterial disorders of lower extremities.All the patients had a history of chronic ischemia of lower limb for an average of (20 ± 9) months (3-60 months).Anklebrachial index (ABI) was 0.00-0.65 with a mean of (0.33 ± 0.22).Results The mean time of thrombolysis was 72 hours (within a range of 24-120 h).The D-dimer level multiplied next day after thrombolysis.The occluded length of the diseased arteries before the treatment was 60-180 mm,with a mean of (90 ± 27) mm.After catheter-directed thrombolysis,the occluded length decreased to 20-60 mm [mean of (40 ± 15) mm].Thrombolysis was effective in 192 patients (92%).Endovascular angioplasty was successfully completed in all patients after thrombolysis therapy.Postoperative ABI was 0.64-1.0 [mean of (0.86 ± 0.11)].During the perioperative period no complications nor death occurred.Conclusions Under the guidance of the second time window principle for thrombolysis,preparatory catheterdirected thrombolysis together with assisted endovascular angioplasty is an effective and safe treatment for chronic occlusive arterial disorders of the lower extremities.
6.Risk factors associated with the severity of pulmonary embolism in patients with acute deep venous thrombosis of lower extremities.
Xiaoyun LUO ; Fuxian ZHANG ; Email: FUXIAN@263.NET. ; Changming ZHANG ; Lu HU ; Yaping FENG ; Gangzhu LIANG ; Luyuan NIU ; Huan ZHANG ; Long CHENG ; Haoshan QI
Chinese Journal of Surgery 2015;53(8):580-583
OBJECTIVETo identify the risk factors associated with the severity of pulmonary embolism among patients with deep venous thrombosis of lower extremities.
METHODSThis prospective study enrolled 208 patients with acute deep venous thrombosis to screen for pulmonary embolism between July 2010 and July 2012 in Beijing Shijitan Hospital. There were 101 male and 107 female patients, with a mean age of (59 ± 16) years. Gender, age, extension, side of lower extremities of deep venous thrombosis was analyzed by χ² test. Ordinal Logistic regression was used to determine risk factors associated with severity of pulmonary embolism.
RESULTSThere were 83 patients with iliofemoral deep venous thrombosis, 102 patients with femoropopliteal and 23 patients with calf deep venous thrombosis. Pulmonary embolism was detected in 70 patients with the incidence of 33.7%. Pulmonary embolism was significantly correlated with extension (χ² = 17.286, P = 0.004) and sides (χ² = 15.602, P = 0.008) of deep venous thrombosis, not with age (χ² = 7.099, P = 0.260), gender (χ² = 7.014, P = 0.067), thrombotic risk factors (χ² = 3.335, P = 0.345) in univariate analysis. Results of multivariate ordinal logistic regression showed that iliofemoral vein thrombosis (OR = 6.172, 95% CI: 1.590 to 23.975, P = 0.009) and bilateral venous thrombosis (OR = 7.140, 95% CI: 2.406 to 24.730, P = 0.001) are associated with more serious pulmonary embolism.
CONCLUSIONSIncidence of pulmonary embolism is still high in patients with deep venous thrombosis. Extensive iliofemoral and bilateral vein thrombosis may increase risk of severity of pulmonary embolism. Clinicians should pay more attention to these high-risk patients.
Acute Disease ; Adult ; Aged ; Female ; Humans ; Incidence ; Logistic Models ; Lower Extremity ; pathology ; Male ; Middle Aged ; Prospective Studies ; Pulmonary Embolism ; diagnosis ; pathology ; Risk Factors ; Veins ; pathology ; Venous Thrombosis ; diagnosis ; pathology
7.11beta-hydroxysteroid dehydrogenase type 2 enzyme activity effect after exposures phthalate esters in maternal.
Xiaoya HU ; Yan ZHAO ; Beitao CHEN ; Yuan LIANG ; Luxi LI ; Changming XIE ; Yunhui ZHANG ; Zhenlang LIN ; Ailan XIE ; Shangqin CHEN
Chinese Journal of Preventive Medicine 2014;48(9):800-804
OBJECTIVETo study the association between phthalate esters (PAEs) metabolites in maternal urine and 11beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2 ) enzyme activity, explore the possible mechanism of PAEs effect on fetal development.
METHODSAll of 33 cases of intrauterine growth retardation (IUGR) newborn were selected by random sampling in 2012. And 33 cases of normal control newborn were enrolled, use high performance liquid chromatography-tandem mass spectrometry method was used to detect 4 kinds of phthalate esters (PAEs) metabolites in maternal urine: mono-n-butyl phthalate ester (MBP), mono (2-ethylhexyl) phthalate (MEHP), mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono (2-ethyl-5-oxohexyl) phthalate (MEOHP) and three kinds of cortisol corticosterone metabolites, tetrahydrocortisol (THF), allo-tetrahydrocortisol (allo-THF), tetrahydrocortisone (THE), and analyze the association between phthalate esters (PAEs) metabolites in maternal urine and 11β-HSD2 enzyme activity.
RESULTSMBP, MEHP, MEHHP, MEOHP metabolites can be detected in 98% (65 cases) , 89% (59 cases), 91% (60 cases), 91% (60 cases) of all 66 maternal urine samples, respectively. The median concentrations of test material in case group were 31.20 ng/ml for MBP, 24.61 ng/ml for MEHHP, 11.72 ng/ml for MEOHP and 48.67 ng/ml for SumDEHP which were significantly higher than those of the control group (were 17.32, 12.03, 5.68 and 28.64 ng/ml); 11β-HSD2 activity in case group ((THF+allo-THF)/THE = (0.79 ± 0.09) ng/ml) was significantly lower than that of the control group((THF+allo-THF)/THE = (0.58 ± 0.04) ng/ml); PAEs metabolites MBP (β' = 1.12), MEHHP(β' = 1.14), MEOHP(β' = 1.10), SumDEHP(β' = 1.08) in baby boy mother's urine was reversely correlated to 11β-HSD2 activity.
CONCLUSIONSPAEs could affect fetal development by inhibit 11β-HSD2 activity.
11-beta-Hydroxysteroid Dehydrogenase Type 2 ; Chromatography, Liquid ; Diethylhexyl Phthalate ; analogs & derivatives ; Fetal Development ; Humans ; Infant, Newborn ; Male ; Mass Spectrometry ; Phthalic Acids ; Tetrahydrocortisol ; analogs & derivatives ; Tetrahydrocortisone
8.Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): Chinese subgroup analysis.
Jiafu JI ; Han LIANG ; Youqing ZHAN ; Yunpeng LIU ; Yulong HE ; Yingjiang YE ; Yihong SUN ; Changming HUANG ; Ming YAN ; Yingqiang SHI ; Aiwen WU
Chinese Journal of Gastrointestinal Surgery 2014;17(2):133-138
OBJECTIVETo evaluate the efficacy and safety profile of XELOX (capecitabine/oxaliplatin) in patients with locally advanced gastric cancer who underwent curative D2 resection in China.
METHODSThis is a subgroup analysis of Chinese patients in the capecitabine and oxaliplatin adjuvant study in stomach cancer (CLASSIC study), which was a randomised, open-label, multicentre, parallel-group, phase III( study in the Asia-Pacific region. A total of 100 gastric cancer patients who received curative D2 gastrectomy were enrolled in this study and were randomly assigned to either XELOX group (oral capecitabine combined with intravenous oxaliplatin chemotherapy) or the control group (surgery alone). This study aims to compare the 3-year disease-free between the two groups.
RESULTSSubgroup analysis showed that 3-year DFS rate were 78% and 56% in XELOX and control group, respectively. The risk of relapse in XELOX group was reduced by 59% (HR=0.41, 95%CI:0.20-0.85, P=0.013), compared with the control group. The 3-year overall survival rate were 78% and 66% in XELOX and control group, with no statistically significant difference (HR=0.55, 95%CI:0.26-1.16, P=0.110).
CONCLUSIONAdjuvant XELOX chemotherapy following D2 gastrectomy may improve the survival in patients with advanced gastric cancer in China.
Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Capecitabine ; Chemotherapy, Adjuvant ; Deoxycytidine ; administration & dosage ; analogs & derivatives ; Disease-Free Survival ; Fluorouracil ; administration & dosage ; analogs & derivatives ; Gastrectomy ; Humans ; Neoplasm Recurrence, Local ; Organoplatinum Compounds ; administration & dosage ; Stomach Neoplasms ; drug therapy ; surgery ; Survival Rate
9.11beta-hydroxysteroid dehydrogenase type 2 enzyme activity effect after exposures phthalate esters in maternal
Xiaoya HU ; Yan ZHAO ; Beitao CHEN ; Yuan LIANG ; Luxi LI ; Changming XIE ; Yunhui ZHANG ; Zhenlang LIN ; Ailan XIE ; Shangqin CHEN
Chinese Journal of Preventive Medicine 2014;(9):800-804
Objective To study the association between phthalate esters ( PAEs ) metabolites in maternal urine and 11beta-hydroxysteroid dehydrogenase type 2(11β-HSD2 ) enzyme activity, explore the possible mechanism of PAEs effect on fetal development.Methods All of 33 cases of intrauterine growth retardation ( IUGR) newborn were selected by random sampling in 2012.And 33 cases of normal control newborn were enrolled , use high performance liquid chromatography-tandem mass spectrometry method was used to detect 4 kinds of phthalate esters ( PAEs) metabolites in maternal urine:mono-n-butyl phthalate ester (MBP), mono (2-ethylhexyl) phthalate (MEHP), mono (2-ethyl-5-hydroxyhexyl) phthalate(MEHHP), mono ( 2-ethyl-5-oxohexyl ) phthalate ( MEOHP ) and three kinds of cortisol corticosterone metabolites , tetrahydrocortisol (THF), allo-tetrahydrocortisol (allo-THF), tetrahydrocortisone (THE), and analyze the association between phthalate esters ( PAEs) metabolites in maternal urine and 11β-HSD2 enzyme activity.Results MBP,MEHP,MEHHP,MEOHP metabolites can be detected in 98%(65 cases),89%(59 cases), 91%(60 cases),91%(60 cases)of all 66 maternal urine samples, respectively.The median concentrations of test material in case group were 31.20 ng/ml for MBP, 24.61 ng/ml for MEHHP, 11.72 ng/ml for MEOHP and 48.67 ng/ml for SumDEHP which were significantly higher than those of the control group ( were 17.32,12.03,5.68 and 28.64 ng/ml); 11β-HSD2 activity in case group (( THF +allo-THF)/THE =(0.79 ±0.09) ng/ml) was significantly lower than that of the control group (( THF+allo-THF)/THE=(0.58 ±0.04) ng/ml);PAEs metabolites MBP(β′=1.12),MEHHP(β′=1.14),MEOHP(β′=1.10), SumDEHP (β′=1.08 ) in baby boy mother′s urine was reversely correlated to 11β-HSD2 activity.Conclusions PAEs could affect fetal development by inhibit 11β-HSD2 activity.
10.11beta-hydroxysteroid dehydrogenase type 2 enzyme activity effect after exposures phthalate esters in maternal
Xiaoya HU ; Yan ZHAO ; Beitao CHEN ; Yuan LIANG ; Luxi LI ; Changming XIE ; Yunhui ZHANG ; Zhenlang LIN ; Ailan XIE ; Shangqin CHEN
Chinese Journal of Preventive Medicine 2014;(9):800-804
Objective To study the association between phthalate esters ( PAEs ) metabolites in maternal urine and 11beta-hydroxysteroid dehydrogenase type 2(11β-HSD2 ) enzyme activity, explore the possible mechanism of PAEs effect on fetal development.Methods All of 33 cases of intrauterine growth retardation ( IUGR) newborn were selected by random sampling in 2012.And 33 cases of normal control newborn were enrolled , use high performance liquid chromatography-tandem mass spectrometry method was used to detect 4 kinds of phthalate esters ( PAEs) metabolites in maternal urine:mono-n-butyl phthalate ester (MBP), mono (2-ethylhexyl) phthalate (MEHP), mono (2-ethyl-5-hydroxyhexyl) phthalate(MEHHP), mono ( 2-ethyl-5-oxohexyl ) phthalate ( MEOHP ) and three kinds of cortisol corticosterone metabolites , tetrahydrocortisol (THF), allo-tetrahydrocortisol (allo-THF), tetrahydrocortisone (THE), and analyze the association between phthalate esters ( PAEs) metabolites in maternal urine and 11β-HSD2 enzyme activity.Results MBP,MEHP,MEHHP,MEOHP metabolites can be detected in 98%(65 cases),89%(59 cases), 91%(60 cases),91%(60 cases)of all 66 maternal urine samples, respectively.The median concentrations of test material in case group were 31.20 ng/ml for MBP, 24.61 ng/ml for MEHHP, 11.72 ng/ml for MEOHP and 48.67 ng/ml for SumDEHP which were significantly higher than those of the control group ( were 17.32,12.03,5.68 and 28.64 ng/ml); 11β-HSD2 activity in case group (( THF +allo-THF)/THE =(0.79 ±0.09) ng/ml) was significantly lower than that of the control group (( THF+allo-THF)/THE=(0.58 ±0.04) ng/ml);PAEs metabolites MBP(β′=1.12),MEHHP(β′=1.14),MEOHP(β′=1.10), SumDEHP (β′=1.08 ) in baby boy mother′s urine was reversely correlated to 11β-HSD2 activity.Conclusions PAEs could affect fetal development by inhibit 11β-HSD2 activity.

Result Analysis
Print
Save
E-mail